Our study showed that the combined AAb panel (p53, GAGE7, PGP9.5, CAGE, MAGEA1, SOX2, and GBU4-5) could differentiate patients with lung cancer from healthy controls and patients with benign lung disease. Here, SOX2 is linked to lung cancer.